Pembrolizumab with chemotherapy then olaparib maintenance for treating BRCA-negative advanced epithelial ovarian, fallopian tube or peritoneal cancer [ID3853]

  • In development
  • GID-TA10747
  • Expected publication date: TBC

Documents

Documents created during the development process.

Notes